Dec. 1, 2025 — Medimaps Group S.A., a provider of AI-driven bone microarchitecture imaging solutions, will make the first live presentations of its new software TBS Reveal* at the Radiological Society of North America (RSNA) 2025 Annual Meeting, in Chicago, IL.
Building on its Trabecular Bone Score (TBS) technology, Medimaps Group will showcase its new AI-driven software TBS Reveal, alongside its latest software solution TBS Osteo Advanced, launched in the United States earlier this year. Together, these solutions empower radiologists to detect bone fragility using X-ray and DXA modalities.
TBS Reveal is an AI-powered software solution leveraging Trabecular Bone Score (TBS) for X-ray scans. Working seamlessly with conventional X-ray images within existing PACS workflows, TBS Reveal* uniquely assesses combined bone microarchitecture and bone mass to opportunistically detect bone fragilities earlier, enabling further clinical investigation. The software’s performance has been validated through external studies using paired DXA and X-ray data from patients aged 20 and older, demonstrating 90% accuracy, 95% specificity, and a strong 85% AUC.
TBS Reveal has been submitted to the U.S. Food and Drug Administration (FDA) under the 510(k) procedure.
“Conventional X-rays are among the most common imaging modalities in clinical practice, yet they are rarely used to assess bone fragility, a missed opportunity given the vast number of images processed and already stored in PACS systems,” said Univ-Prof. Dr. Didier Hans, CEO and Co-founder of Medimaps Group. “By applying AI to analyze these X-ray images with our TBS technology, TBS Reveal* can help flag patients at elevated risk of bone fracture and guide them toward early diagnostic assessment. Because it captures bone quality, not just density, it provides a far more powerful view of bone fragility from a routine X-ray.”
At RSNA 2025, Medimaps Group will provide an exclusive introduction of TBS Reveal with two presentations:
Smarter, Not Louder: Sustainable AI for Bone Fragility Detection from X-Rays – Beyond the Fracture (AI Theater Presentation)
Date: Dec. 1, 2025
Time: 1:00
Location: RSNA AI Theater, South Hall
TBS Reveal*: One-Click AI Bone Fragility Detection from X-Ray (company workshop)
Date: Dec. 2, 2025
Time: 1:00
Location: Medimaps Group Booth #5728, South Hall
TBS is a proprietary technology from Medimaps Group. This advanced analytical method extracts a grey-level texture index from DXA, and now from X-ray, to assess bone microarchitecture. Referenced in more than 1,500 scientific publications and 35 clinical guidelines, TBS has proven to be an effective adjunct or a standalone measure for fracture risk prediction in clinical practice enabling to detect and classify more patients as osteoporotic.
*TBS Reveal is currently pending FDA clearance.
March 18, 2026 
